Cargando…

A Dual Peptide Sustained-Release System Based on Nanohydroxyapatite/Polyamide 66 Scaffold for Synergistic-Enhancing Diabetic Rats’ Fracture Healing in Osteogenesis and Angiogenesis

Diabetes mellitus impairs fracture healing and function of stem cells related to bone regeneration; thus, effective bone tissue engineering therapies can intervene with those dysfunctions. Nanohydroxyapatite/polyamide 66 (n-HA/PA66) scaffold has been used in fracture healing, whereas the low bioacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jian, Wei, Jiaxing, Li, Ang, Liu, Hongyu, Sun, Jingxue, Qiao, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188490/
https://www.ncbi.nlm.nih.gov/pubmed/34124019
http://dx.doi.org/10.3389/fbioe.2021.657699
_version_ 1783705339806351360
author Li, Jian
Wei, Jiaxing
Li, Ang
Liu, Hongyu
Sun, Jingxue
Qiao, Hong
author_facet Li, Jian
Wei, Jiaxing
Li, Ang
Liu, Hongyu
Sun, Jingxue
Qiao, Hong
author_sort Li, Jian
collection PubMed
description Diabetes mellitus impairs fracture healing and function of stem cells related to bone regeneration; thus, effective bone tissue engineering therapies can intervene with those dysfunctions. Nanohydroxyapatite/polyamide 66 (n-HA/PA66) scaffold has been used in fracture healing, whereas the low bioactivity limits its further application. Herein, we developed a novel bone morphogenetic protein-2- (BMP-2) and vascular endothelial growth factor- (VEGF) derived peptides-decorated n-HA/PA66 (BVHP66) scaffold for diabetic fracture. The n-HA/PA66 scaffold was functionalized by covalent grafting of BMP-2 and VEGF peptides to construct a dual peptide sustained-release system. The structural characteristics and peptide release profiles of BVHP66 scaffold were tested by scanning electron microscopy, Fourier transform infrared spectroscopy, and fluorescence microscope. Under high glucose (HG) condition, the effect of BVHP66 scaffold on rat bone marrow mesenchymal stem cells’ (rBMSCs) adherent, proliferative, and differentiate capacities and human umbilical vein endothelial cells’ (HUVECs) proliferative and tube formation capacities was assessed. Finally, the BVHP66 scaffold was applied to fracture of diabetic rats, and its effect on osteogenesis and angiogenesis was evaluated. In vitro, the peptide loaded on the BVHP66 scaffold was in a sustained-release mode of 14 days. The BVHP66 scaffold significantly promoted rBMSCs’ and HUVECs’ proliferation and improved osteogenic differentiation of rBMSCs and tube formation of HUVECs in HG environment. In vivo, the BVHP66 scaffold enhanced osteogenesis and angiogenesis, rescuing the poor fracture healing in diabetic rats. Comparing with single peptide modification, the dual peptide-modified scaffold had a synergetic effect on bone regeneration in vivo. Overall, this study reported a novel BVHP66 scaffold with excellent biocompatibility and bioactive property and its application in diabetic fracture.
format Online
Article
Text
id pubmed-8188490
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81884902021-06-10 A Dual Peptide Sustained-Release System Based on Nanohydroxyapatite/Polyamide 66 Scaffold for Synergistic-Enhancing Diabetic Rats’ Fracture Healing in Osteogenesis and Angiogenesis Li, Jian Wei, Jiaxing Li, Ang Liu, Hongyu Sun, Jingxue Qiao, Hong Front Bioeng Biotechnol Bioengineering and Biotechnology Diabetes mellitus impairs fracture healing and function of stem cells related to bone regeneration; thus, effective bone tissue engineering therapies can intervene with those dysfunctions. Nanohydroxyapatite/polyamide 66 (n-HA/PA66) scaffold has been used in fracture healing, whereas the low bioactivity limits its further application. Herein, we developed a novel bone morphogenetic protein-2- (BMP-2) and vascular endothelial growth factor- (VEGF) derived peptides-decorated n-HA/PA66 (BVHP66) scaffold for diabetic fracture. The n-HA/PA66 scaffold was functionalized by covalent grafting of BMP-2 and VEGF peptides to construct a dual peptide sustained-release system. The structural characteristics and peptide release profiles of BVHP66 scaffold were tested by scanning electron microscopy, Fourier transform infrared spectroscopy, and fluorescence microscope. Under high glucose (HG) condition, the effect of BVHP66 scaffold on rat bone marrow mesenchymal stem cells’ (rBMSCs) adherent, proliferative, and differentiate capacities and human umbilical vein endothelial cells’ (HUVECs) proliferative and tube formation capacities was assessed. Finally, the BVHP66 scaffold was applied to fracture of diabetic rats, and its effect on osteogenesis and angiogenesis was evaluated. In vitro, the peptide loaded on the BVHP66 scaffold was in a sustained-release mode of 14 days. The BVHP66 scaffold significantly promoted rBMSCs’ and HUVECs’ proliferation and improved osteogenic differentiation of rBMSCs and tube formation of HUVECs in HG environment. In vivo, the BVHP66 scaffold enhanced osteogenesis and angiogenesis, rescuing the poor fracture healing in diabetic rats. Comparing with single peptide modification, the dual peptide-modified scaffold had a synergetic effect on bone regeneration in vivo. Overall, this study reported a novel BVHP66 scaffold with excellent biocompatibility and bioactive property and its application in diabetic fracture. Frontiers Media S.A. 2021-05-26 /pmc/articles/PMC8188490/ /pubmed/34124019 http://dx.doi.org/10.3389/fbioe.2021.657699 Text en Copyright © 2021 Li, Wei, Li, Liu, Sun and Qiao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Li, Jian
Wei, Jiaxing
Li, Ang
Liu, Hongyu
Sun, Jingxue
Qiao, Hong
A Dual Peptide Sustained-Release System Based on Nanohydroxyapatite/Polyamide 66 Scaffold for Synergistic-Enhancing Diabetic Rats’ Fracture Healing in Osteogenesis and Angiogenesis
title A Dual Peptide Sustained-Release System Based on Nanohydroxyapatite/Polyamide 66 Scaffold for Synergistic-Enhancing Diabetic Rats’ Fracture Healing in Osteogenesis and Angiogenesis
title_full A Dual Peptide Sustained-Release System Based on Nanohydroxyapatite/Polyamide 66 Scaffold for Synergistic-Enhancing Diabetic Rats’ Fracture Healing in Osteogenesis and Angiogenesis
title_fullStr A Dual Peptide Sustained-Release System Based on Nanohydroxyapatite/Polyamide 66 Scaffold for Synergistic-Enhancing Diabetic Rats’ Fracture Healing in Osteogenesis and Angiogenesis
title_full_unstemmed A Dual Peptide Sustained-Release System Based on Nanohydroxyapatite/Polyamide 66 Scaffold for Synergistic-Enhancing Diabetic Rats’ Fracture Healing in Osteogenesis and Angiogenesis
title_short A Dual Peptide Sustained-Release System Based on Nanohydroxyapatite/Polyamide 66 Scaffold for Synergistic-Enhancing Diabetic Rats’ Fracture Healing in Osteogenesis and Angiogenesis
title_sort dual peptide sustained-release system based on nanohydroxyapatite/polyamide 66 scaffold for synergistic-enhancing diabetic rats’ fracture healing in osteogenesis and angiogenesis
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188490/
https://www.ncbi.nlm.nih.gov/pubmed/34124019
http://dx.doi.org/10.3389/fbioe.2021.657699
work_keys_str_mv AT lijian adualpeptidesustainedreleasesystembasedonnanohydroxyapatitepolyamide66scaffoldforsynergisticenhancingdiabeticratsfracturehealinginosteogenesisandangiogenesis
AT weijiaxing adualpeptidesustainedreleasesystembasedonnanohydroxyapatitepolyamide66scaffoldforsynergisticenhancingdiabeticratsfracturehealinginosteogenesisandangiogenesis
AT liang adualpeptidesustainedreleasesystembasedonnanohydroxyapatitepolyamide66scaffoldforsynergisticenhancingdiabeticratsfracturehealinginosteogenesisandangiogenesis
AT liuhongyu adualpeptidesustainedreleasesystembasedonnanohydroxyapatitepolyamide66scaffoldforsynergisticenhancingdiabeticratsfracturehealinginosteogenesisandangiogenesis
AT sunjingxue adualpeptidesustainedreleasesystembasedonnanohydroxyapatitepolyamide66scaffoldforsynergisticenhancingdiabeticratsfracturehealinginosteogenesisandangiogenesis
AT qiaohong adualpeptidesustainedreleasesystembasedonnanohydroxyapatitepolyamide66scaffoldforsynergisticenhancingdiabeticratsfracturehealinginosteogenesisandangiogenesis
AT lijian dualpeptidesustainedreleasesystembasedonnanohydroxyapatitepolyamide66scaffoldforsynergisticenhancingdiabeticratsfracturehealinginosteogenesisandangiogenesis
AT weijiaxing dualpeptidesustainedreleasesystembasedonnanohydroxyapatitepolyamide66scaffoldforsynergisticenhancingdiabeticratsfracturehealinginosteogenesisandangiogenesis
AT liang dualpeptidesustainedreleasesystembasedonnanohydroxyapatitepolyamide66scaffoldforsynergisticenhancingdiabeticratsfracturehealinginosteogenesisandangiogenesis
AT liuhongyu dualpeptidesustainedreleasesystembasedonnanohydroxyapatitepolyamide66scaffoldforsynergisticenhancingdiabeticratsfracturehealinginosteogenesisandangiogenesis
AT sunjingxue dualpeptidesustainedreleasesystembasedonnanohydroxyapatitepolyamide66scaffoldforsynergisticenhancingdiabeticratsfracturehealinginosteogenesisandangiogenesis
AT qiaohong dualpeptidesustainedreleasesystembasedonnanohydroxyapatitepolyamide66scaffoldforsynergisticenhancingdiabeticratsfracturehealinginosteogenesisandangiogenesis